Johnson & Johnson 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.
2026 iga nephropathy precision therapeutics clinical landscape covering endpoints, sponsors, phases, geographies, readouts, assets and development white space.
2026 mash and liver fibrosis therapeutics clinical landscape covering endpoints, sponsors, phases, geographies, readouts, assets and development white space.
2026 adc competition in non-small cell lung cancer clinical landscape covering endpoints, sponsors, phases, geographies, readouts, assets and development white space.